Rapid Dose Therapeutics Corp. (CSE:DOSE)

Market Cap	26.38M
Revenue (ttm)	1.61M
Net Income (ttm)	-5.78M
Shares Out	131.89M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	44,057
Open	0.2100
Previous Close	0.2000
Day's Range	0.2100 - 0.2100
52-Week Range	0.1250 - 0.3250
Beta	-0.21
RSI	51.12
Earnings Date	Jun 27, 2025

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products....

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Mark Upsdell
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: DOSE

Financial Performance

In 2023, Rapid Dose Therapeutics's revenue was 1.02 million, an increase of 42.06% compared to the previous year's 718,298. Losses were -4.31 million, 13.0% more than in 2022.